Dosing of antidepressants in relation to body weight in children and adolescents with overweight

Overweight and obesity in children and adolescents may impact pharmacokinetics and drug exposure. The aim of the present study was to evaluate doses of antidepressants in relation to body weight in children. We used data from the BMI Epidemiology Study (BEST) Gothenburg cohort and the National Presc...

Full description

Saved in:
Bibliographic Details
Published in:International Journal of Obesity 2024-11
Main Authors: Izsak, Julia, Kimland, Elin E, Martikainen, Jari, Dahlén, Elin, Kindblom, Jenny M
Format: Article
Language:English
Subjects:
Endocrinology and Diabetes
Endokrinologi och diabetes
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Overweight and obesity in children and adolescents may impact pharmacokinetics and drug exposure. The aim of the present study was to evaluate doses of antidepressants in relation to body weight in children. We used data from the BMI Epidemiology Study (BEST) Gothenburg cohort and the National Prescribed Drug Register and included children and adolescents with a prescription of fluoxetine (n = 347) or sertraline (n = 733) and a weight measurement. For fluoxetine, individuals with overweight or obesity received slightly lower doses at first prescriptions, but not in iterated prescriptions. The weight-normalized dose was lower in individuals with overweight or obesity in first and iterated prescriptions, compared with normal weight (p 
ISSN:0307-0565
1476-5497
1476-5497
DOI:10.1038/s41366-024-01677-2